Healthcare -
Biotechnology - NASDAQ - US
$ 21.06
1.1 %
$ 1.03 B
Market Cap
-11.14
P/E
ELVN - OPERATING INCOME
Operating Income ELVN - Enliven Therapeutics, Inc.
-83.5 M
LAST VALUE
-83.66%
2 YEAR CAGR
-50.90%
5 YEAR CAGR
0.00%
10 YEAR CAGR